Prezzo Variazione Volume P/E
1.22 +0.15 €
0 -2.65


Altri utenti che hanno investito

Transations in last week
Buy: 70
Sell : 7

0202 bluburro7 Richie Rich Abramh Lincoln Richi Mantovani hamza500 Simone Bonzanini Obl1



This RSS feed URL is deprecated


EyePoint Pharmaceuticals (EYPT) Catches Eye: Stock Jumps 6.8% - Nasdaq

EyePoint Pharmaceuticals, Inc.EYPT was a big mover last session, as the company saw its shares rise nearly 7% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This stock, which remained ...altro » Leggi

Implantable Drug Delivery Devices Market 2018 Market Dynamics, Opportunities, Import/Export, Manufacturers, Growth ... - Trade Market Research

Implantable Drug Delivery Devices market report contains a comprehensive analysis of the important segments to deliver insights on the Market dynamics, which would enable the investors to capitalize on prevailing market opportunities. Implantable Drug ... Leggi

Implantable Drug Market to reach USD 536.72 billion by 2025 - Trade Market Research

... for the market. Top Leading Companies: Bayer, Boston Scientific , Medtronic, Merck&Co. Inc., Allergan Inc., Bausch AndLomb Inc., Ithetis, Nucletron, Genetech Inc., Theragenics, Psivida, Kinamed Inc., K2M Inc., Mako Surgical Corp., Varian Medical ...altro » Leggi

Eyepoint Pharmaceuticals Inc (NASDAQ:EYPT) Gets Yet More Juice Flowing on the YUTIQ Approval - FDA Headlines

The biotech industry is flourishing, yet most traders lack the tools and guidance to profit and profit consistently. Lucky for ... The company was formerly known as pSivida Corp. and changed its name to EyePoint Pharmaceuticals, Inc. in March 2018 ...altro » Leggi

Zacks Investment Research Lowers Eyepoint Pharmaceuticals (EYPT) to Sell - PressOracle

... consists of DEXYCU(TM). EyePoint Pharmaceuticals Inc., formerly known as pSivida Corp., is headquartered in Watertown, MA. “ ... Shares of Eyepoint Pharmaceuticals stock traded up $0.17 during trading on Monday, hitting $3.23. The stock had a ...altro » Leggi

pSivida Corp. Announces Transformative Acquisition of Icon Bioscience Inc. and Growth Capital Financing with Essex ... - GlobeNewswire (press release)

Due to a significant decrease in the proportion of the Company's common stock held by Australian shareholders, low trading activity and the costs of maintaining the listing, the Board of Directors of pSivida after careful consideration has determined ...altro » Leggi

Eyepoint Pharmaceuticals (NASDAQ:EYPT) Stock Rating Lowered by Zacks Investment Research - Marea Informative (blog)

Zacks Investment Research downgraded shares of Eyepoint Pharmaceuticals (NASDAQ:EYPT) from a hold rating to a sell rating in a research report sent to investors on Monday, September 17th. According to Zacks, “EyePoint Pharmaceuticals Inc. operates ...altro » Leggi

Global Uveitis Treatment Market 2018- Novartis, Valeant Pharmaceutical International, EyeGate Pharmaceuticals - The Future Gadgets

The new research report on Global Uveitis Treatment Market covers the data which is helpful for top manufacturers, product scope, market overview, market opportunities, market risk, market driving force, technological advancement, distributors, traders ...altro » Leggi

Implantable Drug Delivery Devices Market Anticipated to Reach at a CAGR of 7.9% by 2023 - Trade Market Research

The Implantable Drug Delivery Devices Market report profiles the following companies, which includes Allergan Inc., Bayer HealthCare, Medtronic Inc., Nucletron, Merck, PSivida Corp., Boston Scientific Corporation, Abbott Laboratories, Bausch and Lomb ... Leggi

Analysts' Recent Ratings Changes for Eyepoint Pharmaceuticals (EYPT) - Marea Informative (blog)

EyePoint Pharmaceuticals Inc., formerly known as pSivida Corp., is headquartered in Watertown, MA. “ 9/13/2018 – Eyepoint ... Shares of Eyepoint Pharmaceuticals stock traded up $0.09 on Monday, hitting $2.69. 713,900 shares of the company's stock ...altro » Leggi